
RCT Study
Embryo Predict demonstrated non-inferiority to traditional morphological assessment performed by experienced embryologists, with zero device-related adverse events.
Read More
Reader Study
In cases where there was consensus amongst all 5 embryologists about the top embryo, and the AI disagreed with the consensus, the AI achieved a statistically significant improvement of 8.6% greater in clinical pregnancy rate as compared to the embryologist consensus on the top embryo for transfer.
Read More

Embryo Predict is indicated to analyze images of Day 5, 6, and 7 blastocyst-stage embryos that have been deemed suitable for transfer by the embryologist. The device provides adjunctive information to aid in the assessment of blastocysts when there are multiple embryos deemed suitable for transfer or freezing based on standard morphological assessment.
©2026 by Alife Health
Terms
Privacy
App Privacy
Security
Cookie Declaration
[website version: 740-00200-REC-01 Rev 2]


